Eggersmann, T. K.
Schütt, M.
Becker, J.
Kimmel, M.
Aust, H.
Winkler, J.
Freis, A.
Article History
Received: 13 November 2024
Accepted: 12 February 2025
First Online: 20 February 2025
Declarations
:
: The collected data were saved in compliance with the applicable data processing regulations.
: Not applicable.
: TKE: TKE discloses personal fees and/or research support and/or non-financial support from Ferring Pharmaceuticals Ltd, Merck Healthcare Germany GmbH, Theramex Germany GmbH, Gedeon-Richter Pharma GmBH, Abbott Healthcare Pvt. Ltd, Arthrex GmBH München, Besins Healthcare, IBSA Germany.MS: MS has received personal fees, outside of this study, from Ferring.JB: JB has received personal fees, outside of this study, from Ferring.MK: MK discloses conflict of interest regarding Ferring, Merck Healthcare Germany GmbH, Merck Healthcare KGaA, and Theramex Germany GmbH.HA: HA has received personal fees from Ferring, the D·I·R; and Merck.JW: JW is an employee of Ferring.AF: AF discloses personal fees/research support from Ferring, Merck and Gedeon-Richter.